Evaluating the Communication Between Patients and Providers in Cancer Clinics
Launched by UNIVERSITY OF WISCONSIN, MADISON · May 14, 2025
Trial Information
Current as of September 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to improve how patients communicate with their healthcare team in cancer clinics. It specifically looks at whether a communication tool called TrialTalk™ can help make conversations between patients and doctors better. The goal is to understand how patients feel about their experiences and to see if better communication can help them during their treatment.
To participate, patients need to be at least 18 years old, have a confirmed cancer diagnosis, and identify as Black, African American, or non-Hispanic White. They should also be eligible for certain clinical trials and have had visits with the doctor involved in the study. Participants will fill out questionnaires before and after their regular clinic appointments to share their thoughts on communication. This study is not yet recruiting participants, but it aims to include a variety of voices to help improve care for everyone in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Providers:
- • Hematologists, medical oncologists, or hematology/oncology fellows
- • Willing to complete TrialTalk™ training
- Inclusion Criteria - Patients:
- • ≥ 18 years old
- • have a confirmed diagnosis of cancer
- • identify as Black, African American, or non-Hispanic White
- • potentially eligible for a therapeutic phase I, II or III clinical trial
- • can read and understand English to complete the study questionnaires
- • had previous visits with the enrolled provider
- Exclusion Criteria - Patients:
- • previous enrollment in cancer intervention clinical trial
- • have moderate to severe cognitive impairment
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Chicago, Illinois, United States
Madison, Wisconsin, United States
Patients applied
Trial Officials
Monica Patel, MD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported